Barry J. Simon's Net Worth
$25.9 Million
Who is Barry J. Simon?
Barry J. Simon has an estimated net worth of $25.9 Million. This is based on reported shares across multiple companies, which include ImmunityBio, Inc., Cue Biopharma, Inc., and Viracta Therapeutics, Inc..
SEC CIK
Barry J. Simon's CIK is 0001647994
Past Insider Trading and Trends
2020 was Barry J. Simon's most active year for acquiring shares with 10 total transactions. Barry J. Simon's most active month to acquire stocks was the month of May. 2020 was Barry J. Simon's most active year for disposing of shares, totalling 22 transactions. Barry J. Simon's most active month to dispose stocks was the month of June. 2020 saw Barry J. Simon paying a total of $888,210.54 for 485,234 shares, this is the most they've acquired in one year. In 2015 Barry J. Simon cashed out on 281,762 shares for a total of $2,415,300.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ImmunityBio, Inc. (IBRX) Snapshot price: $3.45
See remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +1.14% | 35.11K |
$3.36 | -$74,235.84 | 3.12M |
Jan 31
| |||
Form 4
| +1.89% | 57.2K |
—
|
—
| 3.09M |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| -3.87% | -125.00K |
$16.14 | -$2,018,056.87 | 3.1M |
May 21 - May 25
| |||
Form 4
| +1.80% | 56.97K |
$1.75 | $99,942.90 | 3.23M |
May 5
| |||
Form 4
|
—
|
0
|
$12.55 | -$466,102.26 | 3.17M |
Scheduled
|
Feb 5
| ||
Form 4
|
—
|
0
|
$11.33 | -$1,530,794.26 | 3.17M |
Scheduled
|
Feb 2
| ||
Form 4
|
—
|
0
|
$11.30 | -$891,283.65 | 3.17M |
Scheduled
|
Jan 27 - Jan 28
| ||
Form 4
|
—
|
0
|
$10.03 | -$2,086,812.00 | 3.17M |
Scheduled
|
Dec 22
| ||
Form 4
|
—
|
0
|
$8.73 | -$1,769,434.28 | 3.17M |
Scheduled
|
Jul 20 - Jul 21
| ||
Form 4
|
—
|
0
|
$7.45 | -$454,631.00 | 3.17M |
Scheduled
|
Jul 8
| ||
Form 4
|
—
|
0
|
$7.38 | -$101.20 | 3.17M |
Scheduled
|
Jun 30
| ||
Form 4
| -0.76% | -24.37K |
$6.16 | -$1,804,570.29 | 3.17M |
Scheduled
|
Jun 19 - Jun 23
| ||
Form 4
| -2.29% | -75.00K |
$7.56 | -$567,337.50 | 3.19M |
Scheduled
|
May 27
| ||
Form 4
| -1.12% | -36.93K |
$5.52 | -$203,698.45 | 3.27M |
Scheduled
|
May 21
| ||
Form 4
| -0.84% | -28.07K |
$5.50 | -$154,508.73 | 3.31M |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
| -0.94% | -32.00K |
$8.12 | -$239,671.20 | 3.36M |
Sep 7 - Sep 8
| |||
Form 4
| +3.25% | 105.83K |
$6.89 | -$546,528.58 | 3.36M |
Jul 27
| |||
Form 4
| +2.79% | 88.54K |
$25.00 | -$2,415,300.00 | 3.26M |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cue Biopharma, Inc. (CUE) Snapshot price: $0.7586
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viracta Therapeutics, Inc. (VIRX) Snapshot price: $0.2301
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||